Tweenvest Stocks

OSR Health, Inc. (NasdaqCM: OSRH)

Health Care · Biotechnology · US

$0.25

-20.89% today · -43.8% 1Y

OSR Health, Inc. (NasdaqCM: OSRH) operates in the Biotechnology industry within the Health Care sector. The company is valued at $11.09M and employs 22 people.

Over the last twelve months the share price has lost 43.8%, trading between 0.30 and 1.24.

Tweenvest scores OSR Health, Inc. across four factors: quality 35/100, value 66/100. Its strongest factor is value.

OSRH price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$11.09M
Revenue (TTM)
$1.81M
P/E
EPS
-0.39
Dividend yield
Beta (5Y)
0.57
52-week high
$1.24
52-week low
$0.30
Avg volume (3M)
Shares outstanding
35.10M
Employees
22
Next earnings

About OSR Health, Inc.

OSR Holdings, Inc. operates as a Special Purpose Acquisition Company (SPAC) – essentially a blank check entity. Its primary objective is to execute a substantial business combination, which may take the form of a merger, a capital stock exchange, an asset acquisition, a stock purchase, a reorganization, or other comparable strategic transaction with one or more established businesses. The company was incorporated on February 25, 2020, and maintains its principal office in Bellevue, Washington.

ISIN
US68840D1028
Founded
2020
Listed since
Mar 21, 2023
Exchange
Nasdaq Capital Market
Currency
USD
CompanyMarket capPriceDay
AbbVie Inc.NYSE: ABBV$467.44B$264.52-0.17%
Amgen Inc.NasdaqGS: AMGN$239.95B$443.84+1.03%
Gilead Sciences, Inc.NasdaqGS: GILD$181.95B$146.74+0.42%
Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX$138.79B$547.59-0.08%
Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN$82.73B$828.50-0.66%
argenx SEENXTBR: ARGX$63.06B864.20-4.19%
CSL LimitedASX: CSL$57.94BAU$169.11+0.48%
Moderna, Inc.NasdaqGS: MRNA$55.45B$138.89-4.26%

Browse every Biotechnology company →

Figures last refreshed Aug 18, 2026.